ArticleFrontiers in cardiovascular medicine2026
Left ventricular outflow tract stenting in late presenting transposition physiology with ventricular shunt and pulmonary stenosis: a case series.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricular outflow tract (LVOT) stenting is a palliative strategy for late-presenting d-transposition of the great arteries (d-TGA) with ventricular septal defect (VSD) and severe LVOT obstruction (LVOTO), particularly in settings with limited surgical resources. We reviewed six patients who underwent LVOT stenting at our center. Median age at intervention was 6 months (Q1-Q3: 25 days-18 months) and median weight was 4.0 kg (Q1-Q3: 3.3-5.1 kg). Median stent length was 23 mm (Q1-Q3, 15-29 mm). Median pre-procedural arterial oxygen saturation was 53.5% (Q1-Q3: 51-65%), increasing to median 85.5% (Q1-Q3: 84-89%) following stent implantation. All procedures were technically successful, with no major intraprocedural complications. Median follow-up duration was 6 months (Q1-Q3: 4 days-6 months). Two patients died during follow-up (at 4 days and 6 months), four proceeded to bidirectional cavopulmonary shunt (BCPS) as part of a Fontan pathway, and one had undefined outcomes. No patient achieved biventricular repair. In this series, LVOT stenting provided effective short-term relief of obstruction and improved systemic oxygenation but functioned primarily as a bridge toward single-ventricle (Fontan) palliation, rather than toward biventricular repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.